Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
about
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.Potential new drugs for therapy of chronic obstructive pulmonary disease.Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library.The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.Metal-mediated targeting in the body.A future perspective on the development of chemokine receptor CXCR4 antagonists.Symmetrical bis-tertiary amines as novel CXCR4 inhibitorsDiverse modifications of the 4-methylphenyl moiety of TAK-779 by late-stage Suzuki-Miyaura cross-coupling.Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study.Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.Update on the development of HIV entry inhibitorsInhibitors of HIV-1 protease: 10 years afterEntry and fusion inhibitors of HIVTherapeutic applications of sulfamates
P2860
Q34123595-37E2A6B1-2B19-47E7-8A45-E2EB4FAF57E9Q35164728-5DC5CFA2-F396-41B4-A9F1-58979EC40FA6Q36016645-BB6725EC-5280-4B27-BC35-C6D9C361A9C6Q36212626-7B95F0E4-AF9F-43C2-86A6-10BDE38C14D2Q36318564-F2EFD7E7-BDE0-435F-9033-BB9DECF90BA1Q37351199-1FD9DB7E-A02D-4FDB-912A-517E46343456Q37352728-9485D643-843E-4140-9C62-3FB51C33CC8EQ38060872-D375848A-C03D-4B50-AE42-24542849D0E9Q38089173-A2521BDB-C613-4407-A6F7-8C93A44FE0D6Q39766459-F02F0AD8-E275-4CF0-8561-8D875032F2B9Q43787466-8D329EE9-5143-4F0A-8754-8ADA06392796Q50870345-590A69BE-947B-4CD8-9924-58D89658C66DQ51741248-7DD0B6DB-086C-4BAC-9C2B-4F7622D5FF03Q54266909-24D5B1DC-C523-4B2F-93CD-413D786C9072Q58388992-E95BFE3F-DAA2-4D75-ACD7-3E4324DB16E9Q58389026-F1AA09BD-64A6-47A8-85D5-5D2286E5DE93Q58389047-0EE4EF94-95E3-403B-A602-4E5402B298F5Q58863297-4F4C527A-2489-48C4-887C-B2015AC9AB9B
P2860
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@ast
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@en
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@nl
type
label
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@ast
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@en
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@nl
prefLabel
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@ast
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@en
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@nl
P1476
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
@en
P2093
Antonio Mastrolorenzo
Claudiu T Supuran
P356
10.1080/14756360290024227
P577
2002-04-01T00:00:00Z